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Abstract: Skin absorption and toxicity on keratinocytes of cobalt oxide nanoparticles 
(Co3O4NPs) have been investigated. Co3O4NPs are commonly used in industrial products 
and biomedicine. There is evidence that these nanoparticles can cause membrane damage 
and genotoxicity in vitro, but no data are available on their skin absorption and cytotoxicity 
on keratinocytes. Two independent 24 h in vitro experiments were performed using Franz 
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diffusion cells, using intact (experiment 1) and needle-abraded human skin (experiment 2). 
Co3O4NPs at a concentration of 1000 mg/L in physiological solution were used as donor 
phase. Cobalt content was evaluated by Inductively Coupled–Mass Spectroscopy.  
Co permeation through the skin was demonstrated after 24 h only when damaged skin 
protocol was used (57 ± 38 ng·cm−2), while no significant differences were shown between 
blank cells (0.92 ± 0.03 ng cm−2) and those with intact skin (1.08 ± 0.20 ng·cm−2).  
To further investigate Co3O4NPs toxicity, human-derived HaCaT keratinocytes were 
exposed to Co3O4NPs and cytotoxicity evaluated by MTT, Alamarblue® and propidium 
iodide (PI) uptake assays. The results indicate that a long exposure time (i.e., seven days) 
was necessary to induce a concentration-dependent cell viability reduction (EC50 values:  
1.3 × 10−4 M, 95% CL = 0.8–1.9 × 10−4 M, MTT essay; 3.7 × 10−5 M, 95%  
CI = 2.2–6.1 × 10−5 M, AlamarBlue® assay) that seems to be associated to necrotic events 
(EC50 value: 1.3 × 10−4 M, 95% CL = 0.9–1.9 × 10−4 M, PI assay). This study demonstrated 
that Co3O4NPs can penetrate only damaged skin and is cytotoxic for HaCat cells after long 
term exposure.  
Keywords: cobalt oxide; nanoparticles; in vitro; human skin absorption;  
keratinocytes toxicity 
 
1. Introduction 
The use of nanoparticles (NPs) has grown in the last decades in many fields of every day life,  
and imposes to the scientific community to take into account their toxicological potential. In fact, NPs 
may have an unpredictable impact on human health, since traditional toxicological knowledge, based 
on data derived from materials in their bulk form, is not applicable in the nano size range. One of the 
crucial aspect is NPs penetration into the body and skin can be a crucial route of entry due to skin contact 
and skin contamination that are very common in working conditions, where risk perception of the “skin 
route” is very low. Moreover, to protect workers from inhalation exposure, more NPs are produced as 
suspension decreasing inhalation risk but increasing potentially skin absorption. 
Magnetic nanoparticles have been proposed in many biomedical applications, such as cancer 
diagnosis [1], radioactive vectors in cancer therapy [2], and as drug delivery systems [3]. CoO and Co3O4 
are two important forms among the various cobalt oxides based on their distinctive structural features 
and properties [4] and it has been demonstrated that these transition metal oxides, when falling in the 
nanosized regime, have even more attractive applications such as, e.g. heterogeneous catalysts,  
gas sensors, lithium ion batteries, electrochromic devices, solar energy absorbers, ceramic pigments and 
optical devices, etc. [5–11]. Actually, these NPs are used as contrast agents in magnetic resonance [12], 
as drug delivery system [13] and as adjuvants for use in human vaccination too, especially when both 
lymphocytes Th1 and Th2 responses are needed to clear pathogens [14]. On the other hand,  
some studies demonstrated the induction of membrane damage and genotoxicity in HepG2 cells 
through ROS and oxidative stress due to these NPs [15]. Cobalt oxide NPs are graded as harmful to 
humans and dangerous for the environment, but experimental data are lacking. Concerns arise because 
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Cobalt is also a skin sensitizer [16] and a previous study of our group demonstrated that skin exposure 
to 80 nm CoNPs can lead to skin permeation of this metal [17]. There are no data on cobalt oxide 
nanoparticles behavior through skin barrier. There is the need to study if Co3O4NPs can release ions in 
physiological condition, if they can penetrate and permeate the skin and to understand whether skin 
permeation differs between metal and metal oxides NPs species. 
The aim of this study was to evaluate Co3O4NPs human skin absorption, since consumers and 
workers exposure may increase in the next few years. We used the experience and the protocol employed 
during the European project EDETOX (Evaluations and predictions of DErmal absorption of TOXic 
chemicals), a three-year research program (2001–2004) funded by European Union [18] and already used 
to test the skin permeation of other metal nanoparticles such as silver, gold and cobalt [17,19,20]. 
2. Materials and Methods 
2.1. Chemicals 
All chemicals were analytical grade. Urea, sodium chloride, sodium hydrogenphosphate, potassium 
dihydrogenphosphate, were purchased from Carlo Erba (Milan, Italy); lactic acid (90% v/v) was 
bought from Acros Organics (Geel, Belgium); nitric acid (69.5% v/v), hydrogen peroxide (30% v/v), 
ammonium hydroxide (25% w/v) from Sigma Aldrich (Milan, Italy). Water reagent grade was 
produced with a Millipore purification pack system (milliQ water). 
The commercially available cobalt (II,III) oxide (<50 nm) nanopowder was provided with  
physico-chemical characterization by Sigma (St. Louis, MO, USA).  
2.2. Nanoparticles Characterization 
The Co3O4NPs have been visualized by Transmission Electron Microscopy (TEM) using a 200 kV 
analytical JEM 2200-FS (JEOL Inc., Peabody, MA, USA), once they were dispersed in synthetic sweat 
and at the end of the experiments (after the 24 h exposure time) to visualize the dimensions of the NPs 
and the aggregation state of the donor phase. 
In addition, since the behavior and the aggregation state of the NPs depends strongly on the surface 
charge of the NPs and the ionic strength of the suspension, further characterization using both 
Dynamic Light Scattering (DLS) and Z-potential techniques have been carried out. The measurements 
have been performed using the 90 Plus PALS instrument (Brookhaven Instruments Corporation, 
Holtsville, NY, USA). 
2.3. Nanoparticles Dissolution 
In order to evaluate the ions release from the NPs once they were put in synthetic sweat, 4 mL of 
the donor phase (described in in vitro diffusion system paragraph) have been ultrafiltered using the Amicon 
Ultra-4 centrifugal filters (10K MWCO) supplied by Millipore Corporation, Billerica, MA 01821 USA. 
The ultrafiltration has been performed in centrifuge at 5000 rpm for 30 min in order to remove the 
Co3O4NPs, but not cobalt ions, from the solution. The solution has been analyzed by ICP–AES 
(Inductively Coupled Plasma–Atomic Emission Spectroscopy) to quantify the cobalt concentration. 
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The ultrafiltration has been repeated on three different aliquots at the beginning of the permeation 
experiments, and on other three aliquots at the end of the 24-h and 7-day exposure times. 
2.4. Preparation of Skin Membranes 
Human abdominal full thickness skin was obtained as surgical waste from 2 patients aged  
45–65 years after obtaining ethical committee approval. After the skin excision, subcutaneous fat was 
removed with a scalpel blade and hair was shaved from the epidermal layer, then skin samples were 
stored at −25 °C for a period up to, but not exceeding, 4 months. It has been demonstrated that this 
procedure does not damage skin barrier properties. At the day of the experiment skin samples have 
been defrost in physiological solution at room temperature for a 30 min period and then 4 × 4 cm2 
pieces were cut from each skin specimen and mounted separately on the diffusion cells. Thickness of 
the membranes were <1mm. Damaged skin samples were obtained using a needle-abrasion technique 
described elsewhere [21]. Skin integrity was tested before and after each experiment using electrical 
conductibility by means of a conductometer (Metrohm, 660, Metrohm AG Oberdorfstr. 68 CH-9100 
Herisau) operating at 300 Hz and connected to two stainless steel electrodes [22]. The conductibility 
data in μS were converted into KΩ cm−2. Cells with a resistance lower than 3.95 ± 0.27 KΩ·cm−2 were 
considered to be damaged and rejected, as suggested by Davies et al. [23]. 
2.5. In Vitro Diffusion System 
Percutaneous absorption studies were performed using static diffusion cells following the Franz 
method [24]. The receptor compartment had a mean volume of 14.0 mL and was maintained at 32 °C by 
means of circulation of thermostated water in the jacket surrounding the cell. This temperature value was 
chosen in order to reproduce the hand physiological temperature at normal conditions. The physiological 
solution used as the receptor phase was prepared by dissolving 2.38 g of Na2HP04, 0.19 g of KH2PO4 
and 9 g of NaCl into 1 L of milliQ water (final pH 7.35). The synthetic sweat solution used as donor 
fluid consisted in 0.5% sodium chloride, 0.1% urea and 0.1% lactic acid in milliQ water; pH 4.5 was 
adjusted with ammonia.  
The concentration of the salt in the receptor fluid was approximately the same that can be found in 
blood. The physiological solution used as receiving phase was continuously stirred using a Teflon 
coated magnetic stirrer (made in UK, distributed by VWR International, Milan, Italy). Each piece of 
skin was clamped between the donor and the receptor compartment; the mean exposed skin area was 
3.29 cm2 and the average membranes thickness was 1 mm. Two different experiments were conducted 
using intact (exp. 1) and damaged skin (exp. 2) as described below: 
2.5.1. Experiment 1 
The donor phase has been prepared just before the experiment using a sonicated suspension of 
Co3O4NPs at a concentration of 1000 mg/L dispersed in synthetic sweat at pH 4.5, to reproduce in vivo 
condition. The Co3O4 concentration in the donor phase was confirmed by Inductively Coupled  
Plasma–Atomic Emission Spectroscopy (ICP-AES) analysis prior to the test. At time 0, the exposure 
chambers of 6 Franz diffusion cells were mounted with intact skin samples and filled with 2.5 mL of the 
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donor suspension (606 μg·cm−2) to ensure an infinite dose. The experiment was run for 24 h, and during 
this period 1.5 mL of the dermal bathing solution was removed at selected intervals (4, 8, 12, 16, 24 h) 
and analyzed. Each receptor sample was immediately replaced with an equal volume of fresh 
physiological solution. At 24 h the dermal bathing solution and the donor phase of each diffusion cell 
were recovered for the following analysis. 
2.5.2. Experiment 2 
Experiment 1 was repeated using an abraded skin protocol as suggested by Bronaugh and  
Steward [21] skin was abraded by drawing the point of a 19-gauge hypodermic needle across the 
surface (20 marks in one direction and 20 perpendiculars). As donor solution was used 2.5 mL of 
Co3O4NPs suspension (606 μg·cm−2), dispersed in synthetic sweat at pH 4.5 to ensure an infinite dose. 
2.5.3. Blanks 
For each experiment, two cells were added as blank. The blank cells were treated as the other cells 
with the exception that only synthetic sweat was used in the donor compartment.  
2.5.4. Skin Digestion after the Experiment  
After the experiment, the skin pieces were washed three times with physiological solution to remove 
Co3O4NPs on the skin, then removed from the diffusion cells and treated as follows: skin samples from 
exp. 1 were separated into epidermis and dermis by heat shock, immerging in water at 60 °C for 1 min 
before freezing, while skin samples from exp. 2 were simply stored in a freezer at −25 °C. At the time of 
the analysis, the skin membranes were dried for 2 h at room temperature, then cut into sections, 
weighed and put into beakers with 10 mL of HNO3 69% v/v and 2 mL of H2O2 for digestion.  
They were agitated for 24 h at room temperature than heated at the boiling point until the remaining 
solutions were of 2 mL in volume. The solutions were diluted to a volume of 10 mL with milliQ water 
for the analysis with ICP-AES. 
2.6. Analytical Measurements 
The metal content in the receiving phase and into the skin was analyzed by Inductively Coupled 
Plasma–Mass Spectrometry (ICP-MS) using an ELAN DRC II, (Perkin Elmer, Waltham, USA) 
instrument equipped with dynamic cell reaction (DRC). The calibration curve was prepared by dilution 
of standard solution ranging from 0.5 to 1000 µg/L (cobalt in HNO3 2% mono elemental standard 
solution, Carlo Erba Reagenti, Milano, Italy). The calibration curve and sample solutions were pumped 
in the spray chamber using a peristaltic pump. The blank samples were used to correct for any 
contamination in each batch. The concentration of cobalt was expressed as microgram per liter.  
The accuracy of the method was determined on the basis of the mean values obtained on certified 
reference materials NIST 1643e-1643d trace elements in water (National Institute of Standards and 
Technology). The coefficients of variation ranged from 4% to 8% among series and from 6% to 12% 
between series and the limit of detection, calculated as three standard deviations of the background signal 
obtained on 10 blind samples, were 0.005 µg/L. The laboratory participates in the inter-comparison 
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program for toxicological analysis in biological materials for the determination of cobalt (G-EQUAS 
of the German Society of Occupational and Environmental Medicine). 
Total cobalt concentration in the donor phases and in the solutions resulting from the mineralization 
of the skin sample were performed by Inductively Coupled Plasma–Atomic Emission Spectroscopy  
(ICP-AES) using a Spectroflame Modula E optical plasma interface (OPI) instrument (by SPECTRO, 
Germany). The analysis were conducted using a calibration curve obtained by dilution  
(range: 0–10 mg/L) of Spectrascan® cobalt standard solution for ICP-AES analyses (by Teknolab A/S, 
Norway). The limit of detection (LOD) at the operative wavelength of 228,616 nm was 0.05 mg/L.  
The precision of the measurements as relative standard deviation (RSD %) for the analysis was always 
less than 5%. 
2.6.1. Cell Tests 
Stock solutions of Co3O4 (1 mg/mL ethanol) were diluted to the required concentrations  
(1.5 × 10−7–1.0 × 10−3 M, equivalent to 0.023–1500 μg/cm2) using the cell culture medium and sonicated  
before using.  
2.6.2. Cell Culture 
Immortalized human keratinocyte cell line HaCaT [25] was purchased from Cell Line Service 
(DKFZ, Eppelheim, Germany). Cells were grown in Dulbecco’s Modified Eagle’s medium (DMEM) 
supplemented with 2 mM·L-Glutamine, 100 U/mL penicillin-100 µg/mL streptomycin and 10% fetal 
bovine serum (FBS). Cells were cultured in 75 cm2 cell culture flasks at 37 °C in a 5% CO2 
atmosphere. All cell culture reagents were from Euroclone (Milan, Italy). Cells received fresh medium 
every 3 days and were subcultured every 7 days.  
2.6.3. MTT Assay 
Cells (5 × 103 cells/well) were plated in 96-wells plates for 24 h and then exposed to increasing 
concentrations of Co3O4NPs (1.5 × 10−7–1.0 × 10−3 M, equivalent to 0.023–1500 μg/cm2). After 24 h, 
48 h and 7 days of exposure, cells were washed with PBS and a 10% MTT solution in complete 
medium was added a 10% MTT solution was added, and after 4 h the insoluble crystals were 
solubilized with DMSO [26]. To avoid artifacts in the optical density (OD) values, derived from the 
presence of particles, the solution was centrifuged for 2 minutes at 1300 rpm and transferred in a new 
plate. Plates were read in a Microplate Autoreader (Bio-Tek Instruments) at 540/630 nm. Data are 
reported as % of control and are the mean ± SE of 4 independent experiments performed in triplicate.  
2.6.4. AlamarBlue® Assay 
Cells (15 × 103 cells/well) were cultured in 96-wells plates. After 24 h, culture medium was 
removed and substituted with 200 µL of complete medium and cells exposed to different 
concentrations of Co3O4NPs (1.5 × 10−7–1.0 × 10−3 M, equivalent to 0.023–1500 μg/cm2). After 24 h, 
48 h and 7 days, cells were washed to remove particles and a solution of 10% AlamarBlue® in 
complete medium (final volume 200 μL) was added to each samples. After 4 h of incubation with the 
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reagent in a humidified 5% CO2 atmosphere, the solution was carefully transferred in a black plate. 
Fluorescence intensity was read by a Fluorocount microplate Fluorometer (Packard, Germany) at an 
excitation wavelength of 530 nm and emission wavelength of 590 nm. Data are reported as % of 
control and are the mean ± SE of 4 independent experiments performed in triplicate.  
2.6.5. Propidium Iodide Uptake 
Cells (5 × 103 cells/well) were seeded in 96-wells plates and after 24 h exposed to increasing 
concentrations of Co3O4NPs (1.5 × 10−7–1.0 × 10−3 M, equivalent to 0.023–1500 μg/cm2) for seven days. 
Propidium iodide (PI) uptake was performed as previously described [27,28]. Briefly, after treatment 
cells were washed 2 times with PBS and then rinsed with 200 μL of 3.0 × 10−6 M PI in PBS.  
After 30 min, fluorescence intensity was read by a Fluorocount microplate Fluorometer (Packard, 
Germany) with excitation length of 530 nm and emission length of 590 nm. Thereafter, all the samples 
were permeabilized with 1% Triton-X-100 for 30 minutes to obtain total cell content for each sample 
and fluorescence read. Positive control was obtained permeabilizing untreated cells with 1% Triton-X. 
Data are reported as % of positive control (equal to 100% PI uptake) after normalization on total cell 
content and are the mean ± SE of 3 independent experiments performed in triplicate. 
2.7. Cell Fixation for TEM Analysis 
HaCaT cells were seeded in cell culture dishes and when nearly to confluence, treated with 100 µM 
Co3O4NPs. After 24 h, cells were washed three times and fixed for 1 h in a solution of 2% 
glutaraldehyde (Serva, Heidelberg, Germany) in 0.1 M cacodylate buffer (pH 7.4). The fixed cells 
were washed twice (10 minutes each) with 0.1 M cacodylate buffer and then post-fixed with 1% 
osmium tetroxide for 1 h at 4 °C. Post-fixed samples were dehydrated with an ascending ethanol series 
ending with 100% ethanol and then embedded in Dow epoxy resin (DER332/732; Società Italiana 
Chimici, Rome, Italy). The last resin embedding was made under vacuum. Ultrathin sections were 
prepared with an Ultramicrotome Leica Ultracut UCT (Leica Microsystems, Milan, Italy) equipped 
with a diamond blade Drukker 3 mm (Emme3, Milan Italy). Ultra-thin sections were observed with a 
transmission electron microscope (EM208; Philips, Eindhoven, The Netherlands) and micrographs 
acquired with a Morada camera (Olympus Soft Imaging Solutions (OSIS), Munster, Germany). 
Double stain was not performed to avoid interference with NPs.  
2.8. Statistical Analysis 
Co concentration data (μg·cm−3) in the receptor solution were converted to the total amount that 
penetrated (μg·cm−2), with a correction for dilution due to sample removal. 
Data analysis was performed with Excel for Windows, release 2007 and Stata Software, version 11.0 
(StataCorp LP, College Station, TX, USA). Skin absorption data were reported as mean ± standard 
deviation (SD). The difference among independent data was assessed by means of the Mann-Whitney test.  
Cytotoxicity data were reported as mean ± standard error (SE) of at least three independent 
experiments performed in triplicate. The concentration giving the 50% of the maximal effect (EC50) 
was calculated using the GraphPad software version 4.0 (Prism GraphPad, Inc.; San Diego, CA, USA). 
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3. Results 
3.1. Nanoparticles Characterization 
TEM characterization of cobalt-oxide NPs (Co3O4) specimens showed that NPs were irregular and 
not spherical, with a tendency to form agglomerates of some decades of NPs (Figure 1a,b). The size 
distribution of NPs was narrow and centered around a mean value of 17 ± 0.2 nm [29]. No differences 
in aggregation were found in donor solution at 0 and 24 h The hydrodynamic radius value (RH) 
observed in water was centered in 318 nm, while it changed considerably when assessed in synthetic 
sweat, reaching a value higher than 800 nm (Figure 2) and quite stable during all the time of the 
experiment (824 at t0 and 882 nm at t24). This phenomenon was clearly in agreement with the 
measured Z-potential values, reported in Table 1. The surface charge values suggested that Co3O4NPs 
were more stable in water, thanks to their higher electrostatic stabilization. Results derived from the 
ultrafiltration of the NPs suspension showed that the cobalt concentration was always less than 0.1% of 
the original NPs dispersion. 
 
Figure 1. (a,b) Representative TEM (Transmission Electron Microscopy) images of 
agglomerated Co3O4NPs dispersed in synthetic sweat at the beginning of the experiments 
(bar: a = 500 nm, b = 200 nm). 
Table 1. Comparison of Z-potential values in water and in synthetic sweat. 
Medium 
Specimen 
Water 
Synthetic Sweat 
T = 0 
Synthetic Sweat 
T = 24 h 
Co3O4 
Mean: –19.8 
+/− 1.15 mV
Mean: –18.5 
+/− 3.5 mV 
Mean: –15.9 
+/− 4.2 mV 
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Figure 2. Size distribution of Co3O4NPs in water and in synthetic sweat suspension, 
estimated by DLS (Dynamic Light Scattering). 
3.2. NPs Skin Permeation 
In experiments with intact skin and in blanks, the concentration of cobalt in receiving phases was 
similar without an increase of the cobalt concentration during time and so a permeation flux was not 
achievable (Figure 3). In experiment 2, where damaged skin was used, a metal permeation was found, 
with flux values of 2.1 ± 2.0 ng·cm−2·h−1 and a lag time of 4.3 ± 2.1 h (mean and standard deviation). 
The amount of cobalt permeated through skin in 24 h was significantly higher using the damaged skin 
protocol (57 ± 38 ng·cm−2), while no significant differences were shown in intact skin between blank 
cells (0.92 ± 0.03 ng·cm−2) and those exposed to Co3O4NPs (1.08 ± 0.20 ng·cm−2). 
 
Figure 3. Cobalt permeation profile after skin application of Co3O4NPs on intact and 
damaged skin (main graph). Differences between intact skin, controls exposed to the ultra 
filtered solution, and blanks are reported in the small box (results expressed as means and 
standard deviation). Six replication for each experiment. 
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ICP-AES skin analysis revealed a higher amount of cobalt in epidermis (15.43 ± 3.01 µg·cm−2) than 
in dermis (1.42 ± 0.21 µg·cm−2) in intact skin (exp. 1 p < 0.05, Figure 4a). Damaged skin had lower Co 
content than intact skin (12.31 ± 6.18 µg cm−2 vs 16.85 ± 10.98 µg cm−2, respectively), without reaching 
statistical significance (Figure 4b), suggesting that Co can be “stored” inside the skin. 
 
(a) 
 
(b) 
Figure 4. (a) Cobalt content (µg/cm2) inside each layer of intact skin, exposed to Co3O4NPs 
and only to physiological solution (blank cells). Mean and standard deviation of sixcells 
each. (b) Cobalt content (µg·cm −2) inside the skin (epidermis + derma) of blank cells 
(exposed to physiological solution), intact skin and damaged skin (exposed to Co3O4NPs). 
Mean and standard deviation of six cells each. 
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3.3. Effect of Co3O4NPs on Cell Viability 
Cytotoxicity of Co3O4NPs was evaluated on HaCaT cells using two different viability tests:  
the MTT assay, which is mainly an index of mitochondrial activity, and the AlamarBlue® assay, which 
is an index of total cell viability. Cells were exposed to increasing concentrations of Co3O4NPs  
(1.5 × 10−7–1.0 × 10−3 M) for different times (24 h, 48 h and seven days). As shown in Figure 5, both 
cell viability assays, the MTT reduction assay (Figure 5A) and the AlamarBlue® assay (Figure 5B), 
indicate that at the highest concentration (1.0 × 10−3 M), Co3O4NPs significantly reduced cell viability 
by 47.1% ± 1.6% and 47.6% ± 7.3% (MTT and AlamarBlue® assays, respectively) after 24 h exposure 
and by 25.4% ± 3.9% and 37.3% ± 9.5% (MTT and AlamarBlue® assays, respectively) after 48 h 
exposure. However, only after seven days exposure a  concentration-dependent effect was evidenced 
so that EC50 values could be calculated and were equal to 1.3 × 10−4 M (95% confidence intervals,  
CI = 0.8–1.9 × 10−4 M, equal to 19.6 μg/cm2, CI 12.0–28.6 μg/cm2) and 3.7 × 10−5 M (95%  
CI = 2.2–6.1 × 10−5 M, equal to 5.57 μg/cm2, CI 3.31–9.18 μg/cm2), for the MTT and AlamarBlue® 
assays, respectively. 
 
Figure 5. Cytotoxicity of Co3O4 NPS. Cell viability was measured by MTT assay (A) and 
Alamar Blue assay (B) after 24 h, 48 h and seven days exposure to Co3O4NPs  
(1.5 × 10−7–1.0 × 10−3 M, or 0.023–1500 μg/cm2) on HaCaT cells. Data are reported as % 
of untreated controls (equal to 100% cell viability) and are the mean ± SE of four 
independent experiments performed in triplicate. 
3.4. Effect of Co3O4NPs on Plasma Membrane Damage 
To evaluate if cytotoxicity induced by Co3O4NPs was associated to plasma membrane damage, 
Propidium iodide (PI) uptake was evaluated. As shown in Figure 6, exposure to Co3O4NPs  
(1.5 × 10−7–1.0x10−3 M) for seven days induced a concentration-dependent increase of PI 
incorporation (99.3% ± 0.7%) that at the highest concentration (1.0 × 10−3 M) was comparable to that 
of the positive control, Triton-X-100 (100%). The calculated EC50 value was equal to 1.3 × 10−4 M  
(95% CL = 0.9–1.9 × 10−4 M, equal to 19.6 μg/cm2, CI 13.6–28.6 μg/cm2).  
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Figure 6. PI uptake in HaCaT cells exposed for seven days to Co3O4NPs  
(1.5 × 10−7–1.0 × 10−3 M, or 0.023–1500 μg/cm2). Data are reported as % of PI uptake with 
respect to positive control (Triton X-100, equal to 100% PI uptake) and are the mean ± SE 
of three independent experiments performed in triplicate. 
3.5. Evaluation of Cellular Internalization of NPs Using Electron Microscopy Imaging  
In Figure 7 it is possible to visualize electron-dense clusters of NPs aggregate inside the organelles. 
No NPs were detected inside the nucleus. 
 
Figure 7. Ultrastructure of in vitro culturing keratinocytes exposed for 24 h to Co3O4NPs. 
((a) bar 5um, (b) bar 200 nm, (c) bar 200 nm, (d) bar 100 nm). Electron-dense material of 
NPs aggregate is observed inside the organelles. EV: endocytic vesicles, IS: intercellular 
space, N: nucleus, NM: nuclear membrane, VM: vesicles membrane, M: mitochondria.  
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4. Discussion 
For the first time, we studied skin absorption of cobalt-oxide NPs using an in vitro protocol on 
human skin. Our results add important information on knowledge on NPs interaction with human body 
and help us to understand the human risk related to NPs contamination. We demonstrated that cobalt 
oxide NPs can cross the skin, but only when this barrier is damaged. No absorption at all has been 
demonstrated through intact skin applying Co3O4NPs. No ions release was detected in donor solution. 
It is known that metal NPs can penetrate (into the skin) and permeate (pass through the skin) as 
nanoparticles if they are very small (4 nm for Quantum dots [30]) or, more commonly, they can release 
a high percentage of ions, which eventually cross the skin barrier [20]. The dissolution of NPs is a 
relevant matter for material in nano-size range, since the high surface to volume ratio increases the risk 
of free metal ions release when compared to materials in traditional form [31]. 
For metal oxides, which are more stable and less-soluble than their metal counterpart [32], this release 
is negligible [33,34] and cobalt oxide NPs have been shown to be less toxic than cobalt ions [35] 
Nevertheless, at a cytological level, cobalt oxide NPs can release ions with a Trojan-horse type 
mechanism [32] and cause rapid induction of ROS [35], and with ROS levels higher than those 
induced by cobalt ions [15,29,36,37]. In angiogenic cells exposure to Co3O4NPs significantly reduced 
cell viability and increased pro-inflammatory cytokine gene expression [38]. 
To assess the penetration capability of the cobalt oxide NPs through the skin barrier, we compared 
the results of the present study with the ones obtained in a previous one, where metallic cobalt NPs 
have been tested using a similar protocol, but owned a larger size [17]. Table 2 shows that the metal 
content in damaged skin was similar when Co3O4NPs are used (89.6% respect to CoNPs exp), while 
metal concentration in receiving solution was significantly lower (5.6%) as well as flux through the 
skin (5%). From this point of view, considering also the smaller size of Co3O4NPs, it is possible to 
state that Co3O4NPs are safer than CoNPs, with regard to the permeation of the skin. When intact skin 
is used, only CoNPs can permeate the barrier and Co can be found in receiving phases, while no 
permeation at all was detectable after the application of Co3O4NPs. These differences can be explained 
by the fact that CoNPs can release cobalt ions [39], which can permeate easily the skin, while Co3O4NPs 
are very stable in physiological solution and cannot release ions [33,34], as demonstrated by scientific 
literature and confirmed in this study by the ultra filtration of the solution used as donor phases. 
It can be concluded that when the skin barrier is damaged or affected by diseases that change barrier 
properties metal oxide absorption is feasible. This suggests the need for a better protection in people 
and workers with skin diseases exposed to metal and even to metal oxide NPs, as barrier disruption of 
the skin is common in workers and in atopic subjects [40]. Nevertheless, we demonstrated that our 
cobalt oxide nanoparticles could not permeate the normal skin, confirming that when metal NPs cannot 
release ions, the permeation is not so easy, as was demonstrated for CoNPs, which can release ions. 
Comparison between cobalt oxide NPs, cobalt NPs and cobalt as bulk material [17] permits to 
understand better the potential that metal and metal oxide NPs present in relation to skin absorption. 
As CoNPs can permeate the skin in higher amount than bulk material, as previously demonstrated, our 
cobalt oxide NPs are stable and cobalt content in receiving phases is zero in intact skin and very low 
also in damaged skin. 
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Table 2. Co and Co3O4 concentration (µg/cm2) into the skin and in receiving solution after 
24 h exposure. To compare values with a previous study [26], we standardized results 
considering the different concentration of Co and Co3O4 in donor solution. 
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Donor Suspension 
Co3O4NPs 
(Peak 17 nm) 
606 μg·cm−2 
(445 μg·cm−2 as Cobalt) 
CoNPs 
(Peak 80 nm) 
1000 μg·cm−2 
Co3O4NPs 
Standardized Values 
1000 μg·cm−2 
Mean SD Mean SD Mean % 
Membrane (μg·cm−2) 4.78 0.90 12.0 3.8 10.75 89.6% 
Receiving Solution 
 (ng·cm−2) 
47 41 1870 * 860 106 5.6% 
Flux (ng·cm−2·h−1) 1.7 2.0 76 * 49.3 3.82 5.0% 
* Mann-Whitney test p < 0.01. 
Finally, the cytotoxic properties of Co3O4NPs were characterized on HaCaT cells, a human  
non-tumor keratinocyte cell line that is widely used as a simple model to assess cytotoxicity at the skin 
level [41]. Cytotoxicity was evaluated using a solution with NPs concentration similar to that used in 
permeation studies, performing two different assays: the MTT assay, that relies on the activity of 
mitochondrial dehydrogenases, and the AlamarBlue® assay, that involves also cytoplasmatic 
dehydrogenases [42,43]. In the HaCaT model, both methods evidenced with a similar pattern the ability 
of Co3O4NPs to reduce cell viability. However, an exposure time as long as seven days was required to 
induce a concentration-dependent cytotoxic effect, whereas at shorter exposure times (i.e., 24 or 48 h) a 
significant cytotoxic effect was observed only at the highest concentrations used. To better 
characterize Co3O4NPs-induced cytotoxicity, PI uptake was evaluated after seven days of exposure. 
Under this condition, Co3O4NPs caused a concentration-dependent PI incorporation, index of plasma 
membrane rupture. On the whole, these data demonstrated that Co3O4NPs are able to induce 
significant cytotoxic effects after a long time exposure (i.e., seven days of exposure) and that this 
effect seems to be due to a damage at the plasma membrane level. These data, if confirmed on more 
complex models, could have a significant impact on the evaluation of the human risk associated to 
cutaneous exposure to these NPs. 
5. Conclusions 
Skin absorption of NPs is a matter of concern for workers and users that can be exposed to objects, 
powders and solution containing NPs. Our study demonstrated that Co3O4NPs cannot permeate 
through intact skin and that only a very low concentration of cobalt is detectable in receiving solutions 
when a damaged skin protocol is used. However, our results on cultured keratinocytes suggest that a 
long-term exposure to Co3O4NPs could induce cell damage and necrosis. We thus recommend the use 
of personal protective equipment to avoid contamination of the skin with NPs because the impaired 
skin barrier is common among workers and atopic subjects.  
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